Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Cyclodextrins As Potential Excipients In Pharmaceutical Formulations: Solubilizing And Stabilizing Effects

A. Ahuja, S. Baboota, J. Ali, G. Mustafa
Published 2011 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1562/0031-8655(2001)073<0006:TPOFAI>2.0.CO;2
The Photochemistry of Flutamide and its Inclusion Complex with β-Cyclodextrin. Dramatic Effect of the Microenvironment on the Nature and on the Efficiency of the Photodegradation Pathways¶
S. Sortino (2001)
10.1016/J.JPBA.2005.06.010
Physico-chemical characterization of benzocaine-β-cyclodextrin inclusion complexes
L. D. Pinto (2005)
10.1081/DDC-100101276
Interaction of Antimalarial Agent Artemisinin with Cyclodextrins
M. Usuda (2000)
10.1002/JPS.10443
Enhanced bioavailability of process-induced fast-dissolving ibuprofen cogranulated with beta-cyclodextrin.
M. K. Ghorab (2003)
10.1208/s12249-008-9180-3
Physicochemical Characterization of Efavirenz–Cyclodextrin Inclusion Complexes
Sateeshkumar Sathigari (2008)
10.1016/0928-0987(95)00006-Y
Physicochemical properties and inclusion complex formation of δ-cyclodextrin
Izuru Miyazawa (1995)
10.1046/J.1525-1594.2003.07244.X
The Effect of Cyclodextrins on the In Vitro and In Vivo Properties of Insulin‐Loaded Poly (D,L‐Lactic‐Co‐Glycolic Acid) Microspheres
J. A. Júnior (2003)
10.1002/JHET.5570310501
Applications of NMR spectral techniques for the study of macrocycle host‐organic guest interactions. A short review
T. Wang (1994)
10.1016/S0928-0987(01)00131-2
Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
B. Pose-Vilarnovo (2001)
10.1016/S0731-7085(99)00173-9
Photodegradation of inclusion complexes of isradipine with methyl-β-cyclodextrin
J. Mielcarek (1999)
10.1016/S0378-5173(02)00552-5
Efficacies of cyclodextrin-complexed and liposome-encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages.
I. Salem (2003)
10.1002/JPS.10495
Inclusion of acitretin into cyclodextrins: phase solubility, photostability, and physicochemical characterization.
X. Liu (2003)
10.1016/J.IJPHARM.2006.04.002
Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.
H. Ammar (2006)
10.1002/(SICI)1520-6017(200002)89:2<241::AID-JPS11>3.0.CO;2-0
Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
P. Jarho (2000)
10.1081/DDC-120015359
Interaction of Iodine with 2-Hydroxypropyl-α-cyclodextrin and Its Bactericidal Activity
K. Tomono (2002)
10.1208/s12249-008-9143-8
Preparation and Solid-State Characterization of Inclusion Complexes Formed Between Miconazole and Methyl-β-Cyclodextrin
A. Ribeiro (2008)
10.1007/BF02975212
Solubility and stability of melatonin in propylene glycol and 2-hydroxypropyl-β-cyclodextrin vehicles
B. Lee (1997)
10.1021/bc8001503
Aqueous solubilization of fullerenes using poly(amidoamine) dendrimers bearing cyclodextrin and poly(ethylene glycol).
Chie Kojima (2008)
10.1016/S0378-5173(96)04759-X
Use of a nonlinear least-squares model for the kinetic determination of the stability constant of cyclodextrin inclusion complexes
Y. L. Loukas (1996)
10.1016/J.IJPHARM.2007.01.013
Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin.
M. A. Tomren (2007)
10.1016/S0928-0987(01)00093-8
The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.
P. Mura (2001)
10.1016/S0378-5173(98)00382-2
Improvement of the in vitro dissolution of praziquantel by complexation with α-, β- and γ-cyclodextrins
G. Becket (1999)
10.1081/DDC-100100995
Nimesulide and β-Cyclodextrin Inclusion Complexes: Physicochemical Characterization and Dissolution Rate Studies
K. P. Chowdary (2000)
[Preparation, identification and inclusion actions of irisquinone hydroxypropyl-beta-cyclodextrin inclusion complex].
X. Zhang (2005)
10.1002/JPS.2600750609
Hydroxypropyl-beta-cyclodextrin derivatives: influence of average degree of substitution on complexing ability and surface activity.
B. Mueller (1986)
10.1016/J.EJPB.2003.10.020
Solubility enhancement of celecoxib using β-cyclodextrin inclusion complexes
S. Rawat (2004)
10.1016/S0928-0987(01)00208-1
Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
C. Fernandes (2002)
10.1016/j.bmc.2009.02.044
Binary and ternary inclusion complexes of finasteride in HPbetaCD and polymers: preparation and characterization.
A. C. Asbahr (2009)
10.1016/J.JPBA.2005.06.022
Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Longxiao Liu (2006)
10.1002/(SICI)1520-6017(200002)89:2<275::AID-JPS15>3.0.CO;2-C
Comparative Effects of (SBE)7m‐β‐CD and HP‐β‐CD on the Stability of Two Anti‐neoplastic Agents, Melphalan and Carmustine
David Q. Ma (2000)
10.1016/S0039-9140(99)00280-5
Effect of cyclodextrins on the stability of adriamycin, adriamycinol, adriamycinone and daunomycin.
S. Emara (2000)
10.1021/JS970178S
Inclusion Complexation of Propofol with 2-Hydroxypropyl-β- cyclodextrin. Physicochemical, Nuclear Magnetic Resonance Spectroscopic Studies, and Anesthetic Properties in Rat
G. Trapani (1998)
10.1002/JPS.2600841015
Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins.
U. S. Sharma (1995)
10.1016/j.jsbmb.2008.10.003
Enhancement of 17α-hydroxyprogesterone production from progesterone by biotransformation using hydroxypropyl-β-cyclodextrin complexation technique
J. Manosroi (2008)
10.1002/JPS.2600810719
Improvements in solubility and stability of thalidomide upon complexation with hydroxypropyl-beta-cyclodextrin.
M. Krenn (1992)
10.3109/10837459809028638
Solubility properties of racemic praziquantel and its enantiomers.
S. K. el-Arini (1998)
10.1016/S0378-5173(00)00682-7
Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
E. Suihko (2001)
10.1016/S0378-5173(99)00255-0
New injectable melphalan formulations utilizing (SBE)7m-β-CD or HP-β-CD
David Q. Ma (1999)
10.1021/CR970025P
Cyclodextrin Drug Carrier Systems.
K. Uekama (1998)
10.1016/S0142-9612(01)00005-9
Influence of betacyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices.
M. E. Sangalli (2001)
10.1248/CPB.52.900
Design and evaluation of cyclodextrin-based drug formulation.
K. Uekama (2004)
Albendazole-cyclodextrin complex: enhanced cytotoxicity in ovarian cancer cells.
M. Pourgholami (2008)
10.2478/v10007-008-0029-9
Characterization of ternary complexes of meloxicam-HPβCD and PVP or L-arginine prepared by the spray-drying technique
H. Elmaradny (2008)
10.1007/s12272-009-1130-4
Dihydroartemisinin-cyclodextrin complexation: Solubility and stability
M. T. Ansari (2009)
10.1021/jp808947m
Encapsulation of small ionic molecules within alpha-cyclodextrins.
J. Rodriguez (2009)
Improvement of dissolution characteristics of psoralen by cyclodextrins complexation.
F. Vincieri (1995)
10.1021/JS960075U
Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery.
R. Rajewski (1996)
10.1211/jpp.60.9.0002
Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique
V. R. Shinde (2008)
10.1021/JS980284+
Solubility and Mass and Nuclear Magnetic Resonance Spectroscopic Studies on Interaction of Cyclosporin A with Dimethyl‐α‐ and ‐β‐Cyclodextrins in Aqueous Solution
K. Miyake (1999)
10.1016/S0731-7085(97)00029-0
Novel non-acidic formulations of haloperidol complexed with beta-cyclodextrin derivatives.
Y. L. Loukas (1997)
10.3109/10837459809009858
Binding, molecular mechanics, and thermodynamics of cyclodextrin inclusion complexes with ketoprofen in aqueous medium.
D. Díaz (1998)
10.1002/JPS.10014
The solid-state stability of amorphous quinapril in the presence of beta-cyclodextrins.
J. Li (2002)
10.1002/1522-2683(200109)22:15<3243::AID-ELPS3243>3.0.CO;2-8
Evidences of cyclodextrin‐mediated enantioselective photodegradation of rac‐nicardipine by capillary electrophoresis
R. Pomponio (2001)
10.1016/S0169-409X(98)00056-8
Cyclodextrins in transdermal and rectal delivery.
Matsuda (1999)
10.1016/S0378-5173(03)00368-5
Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia.
C. Holvoet (2003)
10.2174/157016308784746274
Thermodynamic study of cyclodextrins complexation with benzimidazolic antihelmintics in different reaction media.
María-Josefa Bernad-Bernad (2008)
10.1211/jpp.61.01.0004
Improving glyburide solubility and dissolution by complexation with hydroxybutenyl‐β‐cyclodextrin
S. Klein (2009)
10.1046/j.1365-2710.2000.00285.x
2‐Hydroxypropyl‐β‐cyclodextrin increases aqueous solubility and photostability of all‐trans‐retinoic acid
Lin (2000)
10.1208/ps050105
A mucoadhesive, cyclodextrin-based vaginal cream formulation of itraconazole
Marc Karel Jozef François (2008)
10.1016/J.JENVMAN.2004.01.001
Cyclodextrin-enhanced solubilization of pentachlorophenol in water.
K. Hanna (2004)
10.1016/S0928-0987(99)00078-0
Chitosan microspheres with hydrocortisone and hydrocortisone-hydroxypropyl-beta-cyclodextrin inclusion complex.
J. Filipović‐Grčić (2000)
10.1166/JNN.2009.J092
Cyclodextrin polymers as efficient solubilizers of albendazole: complexation and physico-chemical characterization.
Samer Joudieh (2009)
10.1016/j.ejps.2008.11.006
The stability and dissolution properties of solid glucagon/gamma-cyclodextrin powder.
L. Matilainen (2009)
10.2174/1385272043486061
Spectroscopic Studies on Molecular Recognition of Modified Cyclodextrins
Y. Liu (2004)
10.1002/JPS.20325
Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
Y. Zheng (2005)
10.3923/PJBS.2008.656.659
Ultrasonic studies on lamivudine: beta-cyclodextrin and polymer inclusion complexes.
A. Selvam (2008)
10.1248/CPB.37.1059
Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities.
A. Yoshida (1989)
10.1271/BBB.64.731
Effects of Branched Cyclodextrins on the Solubility and Stability of Terpenes
N. Ajisaka (2000)
10.3109/03639049209043682
Thermal behaviour and dissolution properties of naproxen in combinations with chemically modified ß-Cyclodextrins
G. Bettinetti (1992)
Inclusion complexes of nifedipine and other 1.4-dihydropyridine derivatives with cyclodextrins. IV. The UV study on photochemical stability of the inclusion complexes of nisoldipine, nimodipine, nitrendipine and nicardipine with beta-cyclodextrin in the solution.
J. Mielcarek (1995)
10.1016/S0939-6411(01)00144-8
Complexation of phenytoin with some hydrophilic cyclodextrins: effect on aqueous solubility, dissolution rate, and anticonvulsant activity in mice.
A. Latrofa (2001)
10.1016/S0928-0987(01)00214-7
Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent.
Jichao Kang (2002)
10.1080/03639040802220292
Effect of PVP K30 and/or l-Arginine on Stability Constant of Etoricoxib–HPβCD Inclusion Complex: Preparation and Characterization of Etoricoxib–HPβCD Binary System
M. Shah (2009)
10.1016/J.EJPS.2005.01.021
Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
K. L. Yap (2005)
10.1016/S0378-5173(01)00851-1
Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether beta-cyclodextrin.
Y. Nagase (2001)
10.1081/DDC-100105178
Ofloxacin/β-Cyclodextrin Complexation
L. Koester (2001)
10.1211/0022357991776930
Stability of Diclofenac Sodium in the Inclusion Complex with β‐Cyclodextrin in the Solid State
B. Ćwiertnia (1999)
10.1016/J.IJPHARM.2005.09.003
Melarsoprol-cyclodextrins inclusion complexes.
S. Gibaud (2005)
10.1080/03601230600851216
Environmental Significance of the Diclofop-methyl and Cyclodextrin Inclusion Complexes
Xiyun Cai (2006)
10.1016/j.ijpharm.2008.09.046
Complexation with beta-cyclodextrin confers oral activity on the flavonoid dioclein.
B. A. Rezende (2009)
10.1021/JS9802143
Effect of hydroxypropyl-beta-cyclodextrin and pH on the solubility of levemopamil HCl.
R. McCandless (1998)
10.1023/A:1007919719275
The Hemolytic Properties of Chemically Modified Cyclodextrins
M. Bost (1997)
10.1016/S0731-7085(03)00529-6
Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Tayade Pralhad (2004)
10.2174/157016308784746328
Solubilization and stabilization of sodium dicloxacillin by cyclodextrin inclusion.
M. Echezarreta-López (2008)
10.1016/j.ejpb.2008.08.016
In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery.
Ana Figueiras (2009)
10.1016/S0008-6215(02)00049-6
Structural and physicochemical characterization of the inclusion complexes of cyclomaltooligosaccharides (cyclodextrins) with melatonin.
D. Bongiorno (2002)
10.1016/S0378-5173(01)00986-3
Paclitaxel and its formulations.
A. K. Singla (2002)
10.1002/RECL.19931120618
NMR spectroscopy and molecular‐mechanics calculations in supramolecular chemistry
H. Schneider (1993)
10.1021/jp806233c
Kinetic study of thermally stimulated dissociation of inclusion complex of 1-methylcyclopropene with alpha-cyclodextrin by thermal analysis.
T. Neoh (2008)
Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.
M. Faucci (2001)
10.1080/10610279508029487
Reduction of the haemolytic effect in a biologically recognisable β-cyclodextrin
E. Leray (1995)
10.1002/JPS.20106
Nuclear magnetic resonance and molecular modeling analysis of the interaction of the antimalarial drugs artelinic acid and artesunic acid with β‐cyclodextrin
Mark G. Hartell (2004)
10.1021/bm801206f
Cyclodextrin and polysaccharide-based nanogels: entrapment of two hydrophobic molecules, benzophenone and tamoxifen.
S. Daoud-Mahammed (2009)
10.1016/S0731-7085(96)01900-0
Photochemical stability of the inclusion complexes formed by modified 1,4-dihydropyridine derivatives with beta-cyclodextrin.
J. Mielcarek (1997)
10.1016/J.SAA.2007.10.004
Synthesis and characterization of beta-cyclodextrin inclusion complex containing di(8-hydroxyquinoline) magnesium.
J. He (2008)
10.1021/ES801835X
Enhanced solubilization of a metal-organic contaminant mixture (Pb, Sr, Zn, and perchloroethylene) by cyclodextrin.
M. Skold (2008)
10.1016/j.jpba.2008.06.007
Utility of cyclodextrins in the formulation of genistein part 1. Preparation and physicochemical properties of genistein complexes with native cyclodextrins.
Agnes Emma Daruházi (2008)
10.1248/CPB.46.1840
Isolation, Purification and Characterization of Cyclomaltooctadecaose (v-Cyclodextrin), Cyclomaltononadecaose (ζ-Cyclodextrin), Cyclomaltoeicosaose (o-Cyclodextrin) and Cyclomaltoheneicosaose (π-Cyclodextrin)
T. Endo (1998)
10.1081/DDC-100102291
Effect of aging on the dissolution stability of glibenclamide/beta-cyclodextrin complex.
R. Babu (1999)
10.1016/j.saa.2009.03.012
1H NMR titration and quantum calculation for the inclusion complexes of cis-cyclooctene, cis, cis-1, 3-cyclooctadiene and cis, cis-1, 5-cyclooctadiene with beta-cyclodextrin.
Cao Yu-juan (2009)
10.1021/CR960371R
The Stability of Cyclodextrin Complexes in Solution.
K. Connors (1997)
10.1007/s11095-008-9677-1
The Impact of Aqueous Solubility and Dose on the Pharmacokinetic Profiles of Resveratrol
S. Das (2008)
10.1248/CPB.38.176
Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
A. Yoshida (1990)
10.1021/jp802031w
Native and methylated cyclodextrins with positive and negative solubility coefficients in water studied by SAXS and SANS.
André Kusmin (2008)
10.1016/j.saa.2009.01.009
Hydration and self-association of caffeine molecules in aqueous solution: comparative effects of sucrose and beta-cyclodextrin.
M. Mejri (2009)
10.1016/S0039-9140(03)00066-3
Spectrofluorimetric determination of stoichiometry and association constants of the complexes of harmane and harmine with beta-cyclodextrin and chemically modified beta-cyclodextrins.
L. Martín (2003)
10.1016/J.EJPB.2006.11.025
Paclitaxel/beta-cyclodextrin complexes for hyperthermic peritoneal perfusion - formulation and stability.
W. Bouquet (2007)
10.1080/03639040802192798
Development of Glyburide Fast-Dissolving Tablets Based on the Combined Use of Cyclodextrins and Polymers
M. Cirri (2009)
10.1208/s12249-009-9196-3
Quercetin/β-Cyclodextrin Solid Complexes Prepared in Aqueous Solution Followed by Spray-drying or by Physical Mixture
G. Borghetti (2009)
10.1023/A:1016290127371
Hydroxypropyl-β-Cyclodextrin Increases the Aqueous Solubility and Stability of Pilocarpine Prodrugs
P. Jarho (2004)
10.1248/CPB.51.914
Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether beta-cyclodextrin binary and ternary complexes.
L. Ribeiro (2003)
10.1211/jpp.60.11.0003
Effect of pH and water‐soluble polymers on the aqueous solubility of nimesulide in the absence and presence of β‐cyclodextrin derivatives
Christina Alexanian (2008)
10.1002/JPS.2600780517
Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil.
A. Green (1989)
10.1016/J.SAA.2006.07.006
Complexation of quercetin with three kinds of cyclodextrins: an antioxidant study.
C. Jullian (2007)
10.1021/JS950534B
Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.
T. Loftsson (1996)
10.1263/JBB.102.369
Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins.
H. Hamada (2006)
10.1016/S0928-0987(03)00199-4
Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with beta-cyclodextrin and its sulfobutyl ether derivative in solution and solid state.
L. Ribeiro (2003)
10.1016/j.ejpb.2009.02.013
The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione.
A. Lopedota (2009)
10.1016/S0939-6411(02)00056-5
Optimized transdermal delivery of ketoprofen using pH and hydroxypropyl-beta-cyclodextrin as co-enhancers.
S. Sridevi (2002)
10.1081/DDC-120002840
Study of the Complexation Behavior of Tenoxicam with Cyclodextrins in Solution: Improved Solubility and Percutaneous Permeability
E. Larrucea (2002)
10.1021/JS980041H
Increased shelf-life of fosphenytoin: solubilization of a degradant, phenytoin, through complexation with (SBE)7m-beta-CD.
S. Narisawa (1998)
10.1208/s12249-009-9241-2
Formulation and Evaluation of Bioadhesive Buccal Drug Delivery of Tizanidine Hydrochloride Tablets
G. Shanker (2009)
10.1016/S0928-0987(96)00250-3
Crystallization and polymorphic transition behavior of chloramphenicol palmitate in 2-hydroxypropyl-β-cyclodextrin matrix
F. Hirayama (1997)
10.1021/JS980109T
Inclusion complexation of ziprasidone mesylate with beta-cyclodextrin sulfobutyl ether.
Y. Kim (1998)
10.1016/S0169-409X(98)00057-X
Cyclodextrins in peptide and protein delivery.
Irie. (1999)
10.1080/03639040600897093
Solubility and Dissolution Rate of Progesterone-Cyclodextrin-Polymer Systems
M. Lahiani-Skiba (2006)
10.1248/CPB.40.747
Improvement of stability and dissolution of prostaglandin E1 by maltosyl-beta-cyclodextrin in lyophilized formulation.
M. Yamamoto (1992)
[Characterization of microstructure of ibuprofen-hydroxypropyl-beta-cyclodextrin and ibuprofen-beta-cyclodextrin by atomic force microscope].
L. Wang (2008)
10.1016/J.IJPHARM.2005.11.021
Solubilization and quantification of lycopene in aqueous media in the form of cyclodextrin binary systems.
M. Vertzoni (2006)
10.1081/DDC-100100279
The Influence of Diluent on the Release of Theophylline from Hydrophilic Matrix Tablets
M. Pina (2000)
10.1021/ja806620z
Molecular puzzle ring: pseudo[1]rotaxane from a flexible cyclodextrin derivative.
Atsuhisa Miyawaki (2008)
10.1021/jf801389j
Thermal stability of anthocyanin extract of Hibiscus sabdariffa L. in the presence of beta-cyclodextrin.
I. Mourtzinos (2008)
10.1038/sj.gt.3301527
Development of formulations that enhance physical stability of viral vectors for gene therapy
MA Croyle (2001)
10.1016/0024-3205(96)00024-0
Hydroxypropyl-beta-cyclodextrin increases aqueous solubility and stability of anandamide.
P. Jarho (1996)
10.1016/S0378-5173(02)00263-6
Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state.
M. Bayomi (2002)
10.1016/S0304-3894(03)00068-2
Solubilization of the neutral and charged forms of 2,4,6-trichlorophenol by β-cyclodextrin, methyl-β-cyclodextrin and hydroxypropyl-β-cyclodextrin in water
K. Hanna (2003)
10.1002/JPS.20835
A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
N. Denora (2007)
10.1016/S0378-5173(99)00205-7
Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate.
I. Orienti (1999)
10.1002/JPS.20047
Self-association of cyclodextrins and cyclodextrin complexes.
T. Loftsson (2004)
10.1016/j.carres.2008.06.018
Inclusion complexes of bisphenol A with cyclomaltoheptaose (beta-cyclodextrin): solubilization and structure.
Zi-Xin Yang (2008)
10.1208/pt050119
Triamterene-β-cyclodextrin systems: Preparation, characterization and in vivo evaluation
A. Mukne (2008)
10.1081/DDC-100105177
Influence of the Preparation Method on the Physicochemical Properties of Tolbutamide/Cyclodextrin Binary Systems
F. Veiga (2001)
10.1021/JF030332Y
Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
J. Koontz (2003)
10.1016/S0169-409X(98)00092-1
Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development.
Szente (1999)
10.3109/03639049809088532
Evaluation of a sulfobutyl ether beta-cyclodextrin as a solubilizing/stabilizing agent for several drugs.
H. Ueda (1998)
10.1016/j.saa.2008.07.014
Preparation and spectral investigation of inclusion complex of caffeic acid with hydroxypropyl-beta-cyclodextrin.
M. Zhang (2009)
10.1111/j.2042-7158.1995.tb03267.x
Effect of 2‐Hydroxypropyl‐β‐cyclodextrin on Percutaneous Absorption of Methyl Paraben
M. Tanaka (1995)
10.1208/pt020102
Solubilization of cyclosporin A
Y. Ran (2008)
10.1081/DDC-100102294
Preparation and Characterization of Albendazole β-Cyclodextrin Complexes
J. A. Castillo (1999)
10.1211/0022357991777182
Inclusion Complexation of the Sunscreen Agent 2‐Ethylhexyl‐p‐dimethylaminobenzoate with Hydroxypropyl‐β‐cyclodextrin: Effect on Photostability
S. Scalia (1999)
10.1016/j.chemosphere.2008.08.038
Suppression of estrogenic activity of 17-beta-estradiol by beta-cyclodextrin.
K. Oishi (2008)
10.1016/J.BMC.2005.03.051
Inclusion complexes of azadirachtin with native and methylated cyclodextrins: solubilization and binding ability.
Y. Liu (2005)
10.1111/j.1751-1097.1999.tb08250.x
Effect of p‐Cyclodextrin Complexation on the Photochemical and Photosensitizing Properties of Tolmetin: A Steady‐State and Time‐Resolved Study
S. Sortino (1999)
10.1016/J.JPBA.2007.01.016
Complexation of the sunscreen agent, 4-methylbenzylidene camphor with cyclodextrins: effect on photostability and human stratum corneum penetration.
S. Scalia (2007)
10.1208/pt040345
Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir
G. Tirucherai (2008)
10.1016/j.ijpharm.2008.10.026
Studies on coumestrol/beta-cyclodextrin association: Inclusion complex characterization.
C. Franco (2009)
10.1248/CPB.45.532
Isolation, Purification, and Characterization of Cyclomaltodecaose (ε-Cyclodextrin), Cyclomaltoundecaose (ζ-Cyclodextrin) and Cyclomaltotridecaose (θ-Cyclodextrin)
T. Endo (1997)
10.1271/bbb.80609
Preparation and Characterization of Branched β-Cyclodextrins Having α-L-Fucopyranose and a Study of Their Functions
Y. Nishi (2009)
10.1016/j.saa.2008.09.011
Characterization, phase solubility and molecular modeling of alpha-cyclodextrin/pyrimethamine inclusion complex.
Márcia Valéria Gaspar de Araújo (2009)
10.1002/JPS.2600800420
Development of aqueous parenteral formulations for carbamazepine through the use of modified cyclodextrins.
M. Brewster (1991)
Comparison Between Hydroxypropyl b-Cyclodextrin And Polyvinylpyrrolidone As Carriers For Carbamazepine Solid Despersions
V. Londhe (1999)
10.1248/BPB1978.5.741
Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.
T. Irie (1982)
10.1021/jf802823q
Cyclodextrin inclusion complex formation and solid-state characterization of the natural antioxidants alpha-tocopherol and quercetin.
J. Koontz (2009)
10.1016/j.jpba.2008.10.032
Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques.
A. Al-Marzouqi (2009)
10.1081/PDT-200031428
Toward the Development of an Injectable Dosage Form of Propofol: Preparation and Evaluation of Propofol–Sulfobutyl Ether 7‐β‐Cyclodextrin Complex
M. Babu (2004)
10.1166/JNN.2008.285
Ultrafine cellulose acetate fibers with nanoscale structural features.
L. Zhang (2008)
10.1016/S0031-6865(99)00063-1
Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with beta-cyclodextrin.
Y. Ozkan (2000)
10.1016/j.ijpharm.2008.09.034
Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
T. Tao (2009)
10.1016/j.bmc.2008.07.085
Improvement of water solubility of non-competitive AMPA receptor antagonists by complexation with beta-cyclodextrin.
R. Stancanelli (2008)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar